Research has shown that fibroblasts in breast cancer activate HMGB1 release into the tumor microenvironment, where it interacts with RAGE and promotes invasion of breast cancer cells and the expression of programmed death ligand 1 (PD-L1) through the PI3K/AKT signaling pathway (118). Here, AGER is linked to neoplasm.